Citations (94)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
E. von Schoultz, K. Grankvist, H. Gustavsson & R. Henriksson. (1991) Effects of Estramustine on DNA and Cell Membrane in Malignant Glioma Cells. Acta Oncologica 30:6, pages 719-723.
Read now
Read now
Å. Fritjofsson, B. J. Norlén, B. Högberg, M. Rajalakshmi, S. Z. Cekan & E. Diczfalusy. (1981) Hormonal Effects of Different Doses of Estramustine Phosphate (Estracyt®) in Patients with Prostatic Carcinoma. Scandinavian Journal of Urology and Nephrology 15:1, pages 37-44.
Read now
Read now
P. O. Gunnarsson, G. Plym Forshell, Å. Fritjofsson & B. J. Norlén. (1981) Plasma Concentrations of Estramustine Phosphate and Its Major Metabolites in Patients with Prostatic Carcinoma Treated with Different Doses of Estramustine Phosphate (Estracyt®).. Scandinavian Journal of Urology and Nephrology 15:3, pages 201-206.
Read now
Read now
Articles from other publishers (91)
Michal Jurášek, Markéta Černohorská, Jiří Řehulka, Vojtěch Spiwok, Tetyana Sulimenko, Eduarda Dráberová, Maria Darmostuk, Soňa Gurská, Ivo Frydrych, Renata Buriánová, Tomáš Ruml, Marián Hajdúch, Petr Bartůněk, Pavel Dráber, Petr Džubák, Pavel B. Drašar & David Sedlák. (2018) Estradiol dimer inhibits tubulin polymerization and microtubule dynamics. The Journal of Steroid Biochemistry and Molecular Biology 183, pages 68-79.
Crossref
Crossref
Ugir Hossain Sk, Deobrat Dixit & Ellora Sen. (2013) Comparative study of microtubule inhibitors – Estramustine and natural podophyllotoxin conjugated PAMAM dendrimer on glioma cell proliferation. European Journal of Medicinal Chemistry 68, pages 47-57.
Crossref
Crossref
Pijus Saha, Chhanda Debnath & Gervais Bérubé. (2013) Steroid-linked nitrogen mustards as potential anticancer therapeutics: A review. The Journal of Steroid Biochemistry and Molecular Biology 137, pages 271-300.
Crossref
Crossref
M. Breda, G. Basileo & C. A. James. (2003) Simultaneous determination of estramustine phosphate and its four metabolites in human plasma by liquid chromatography–ionspray mass spectrometry. Biomedical Chromatography 18:5, pages 293-301.
Crossref
Crossref
Tait D. ShanafeltCharles LoprinziRandolph MarksPaul NovotnyJeff Sloan. (2004) Are Chemotherapy Response Rates Related to Treatment-Induced Survival Prolongations in Patients With Advanced Cancer?. Journal of Clinical Oncology 22:10, pages 1966-1974.
Crossref
Crossref
Danilo Giribone & Erminia Fontana. (2004) Synthesis of estromustine, estramustine and estramustine phosphate labelled with deuterium. Journal of Labelled Compounds and Radiopharmaceuticals 47:2, pages 161-165.
Crossref
Crossref
Yoshiteru Sumiyoshi, Katsuyoshi Hashine, Hironori Nakatsuzi, Yokihiko Yamashita & Takashi Karashima. (2001) Oral estramustine phosphate and oral etoposide for the treatment of hormone‐refractory prostate cancer. International Journal of Urology 7:7, pages 243-247.
Crossref
Crossref
Long G Wang, Xiao M Liu, Daniel R Budman & Willi Kreis. (1999) Synergistic effect of estramustine and [3′-keto-Bmtl]-[Val2]-cyclosporine (PSC 833) on the inhibition of androgen receptor phosphorylation in LNCaP cells. Biochemical Pharmacology 58:7, pages 1115-1121.
Crossref
Crossref
Zhaocong Chen, Ahmed Fadiel, Ju Fang Jia, Hideki Sakamoto, Rocco Carbone & Frederick Naftolin. (1999) Induction of apoptosis and suppression of clonogenicity of ovarian carcinoma cells with estrogen mustard. Cancer 85:12, pages 2616-2622.
Crossref
Crossref
P Behnam-Motlagh, K.G Engström, R Henriksson & K Grankvist. (1999) Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells. European Journal of Cancer 35:1, pages 145-153.
Crossref
Crossref
Pelle Lidström, Thomas A. Bonasera, Marcela Marquez-M, Sten Nilsson, Mats Bergström & Bengt Långström. (1998) Synthesis and In Vitro Evaluation of [carbonyl-11C]Estramustine and [carbonyl-11C]Estramustine Phosphate. Steroids 63:4, pages 228-234.
Crossref
Crossref
Peter Iversen, Finn Rasmussen, Christian Asmussen, Ib J. Christensen, Jens Eickhoff, Peter Klarskov, Erik Larsen, Peter Mogensen, Soren Mommsen & Palle Rosenkilde. (1997) Estramustine Phosphate Versus Placebo as Second Line Treatment After Orchiectomy in Patients With Metastatic Prostate Cancer. The Journal of Urology, pages 929-934.
Crossref
Crossref
Peter Iversen, Finn Rasmussen, Christian Asmussen, Ib J. Christensen, Jens Eickhoff, Peter Klarskov, Erik Larsen, Peter Mogensen, Soren Mommsen & Palle Rosenkilde. (1997) Estramustine Phosphate Versus Placebo as Second Line Treatment After Orchiectomy in Patients With Metastatic Prostate Cancer: Daproca Study 9002. Journal of Urology 157:3, pages 929-934.
Crossref
Crossref
R. Lee Cox & E. David Crawford. (1995) Estrogens in the Treatment of Prostate Cancer. The Journal of Urology, pages 1991-1998.
Crossref
Crossref
R. Lee CoxE. David Crawford. (1995) Estrogens in the Treatment of Prostate Cancer. Journal of Urology 154:6, pages 1991-1998.
Crossref
Crossref
Juan F. Santibañez, Ricardo B. Maccioni & Jorge Martínez. (2004) The secretion of urokinase‐like plasminogen activator is inhibited by microtubule‐interacting drugs. Cell Biochemistry and Function 13:3, pages 217-225.
Crossref
Crossref
Marwan Fakih, Tracy Replogle, Jeff E. Lehr, Kenneth J. Pienta & Alan Yagoda. (2006) Inhibition of prostate cancer growth by estramustine and colchicine. The Prostate 26:6, pages 310-315.
Crossref
Crossref
Willi Kreis. 1995. Concepts, Mechanisms, and New Targets for Chemotherapy. Concepts, Mechanisms, and New Targets for Chemotherapy
163
184
.
Daizo Yoshida, Ann Cornell-Bell & Joseph M. Piepmeier. (1994) Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and Astrocytes. Neurosurgery 34:5, pages 863-868.
Crossref
Crossref
Daizo Yoshida, Ann Cornell-Bell & Joseph M. Piepmeier. (1994) Selective Antimitotic Effects of Estramustine Correlate with Its Antimicrotubule Properties on Glioblastoma and Astrocytes. Neurosurgery 34:5, pages 863-868.
Crossref
Crossref
Jaimie D. Nathan, David L. Keefe, Marc A. Weinstein, Zhaocong Chen & Frederick Naftolin. (2016) Estrogen Mustard Induces Cell Cycle Arrest of Human Epithelial Ovarian Cancer Cell Lines. Journal of the Society for Gynecologic Investigation 1:1, pages 97-103.
Crossref
Crossref
J. E. Altwein & M. Wirth. 1994. Uroonkologie. Uroonkologie
159
273
.
Surinder K. Chander, Surinder S. Sahota, Thomas R.J. Evans & Yunus A. Luqmani. (1993) The biological evaluation of novel antioestrogens for the treatment of breast cancer. Critical Reviews in Oncology/Hematology 15:3, pages 243-269.
Crossref
Crossref
Joseph M. Piepmeier, David L. Keefe, Marc A. Weinstein, Daizo Yoshida, Jan Zielinski, Ted T. Lin, Zhaochon Chen & Frederick Naftolin. (1993) Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma Cells. Neurosurgery 32:3, pages 422-431.
Crossref
Crossref
Joseph M. Piepmeier, David L. Keefe, Marc A. Weinstein, Daizo Yoshida, Jan Zielinski, Ted T. Lin, Zhaochon Chen & Frederick Naftolin. (1993) Estramustine and Estrone Analogs Rapidly and Reversibly Inhibit Deoxyribonucleic Acid Synthesis and Alter Morphology in Cultured Human Glioblastoma Cells. Neurosurgery 32:3, pages 422???431.
Crossref
Crossref
Zarife Sahenk & J. R. Mendell. (2004) Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule‐associated proteins. Journal of Neuroscience Research 32:4, pages 481-493.
Crossref
Crossref
Daniel Moraga, Antonio Rivas-Berrios, Gustavo Farías, Margareta Wallin & Ricardo B. Maccioni. (1992) Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and TAU. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology 1121:1-2, pages 97-103.
Crossref
Crossref
X. Zhao, G. J. van Steenbrugge & F. H. Schröder. (1992) Differential sensitivity of hormone-responsive and unresponsive human prostate cancer cells (LNCaP) to tumor necrosis factor. Urological Research 20:3, pages 193-197.
Crossref
Crossref
GUY LECLERCQ. 1992. Antitumor Steriods. Antitumor Steriods
11
63
.
S. Eklöv, S. Nilsson, A. Larson, P. Björk & B. Hartley‐Asp. (2006) Evidence for a non‐estrogenic cytostatic effect of estramustine on human prostatic carcinoma cells in vivo. The Prostate 20:1, pages 43-50.
Crossref
Crossref
K Gunnar Engström, Kjell Grankvist & Roger Henriksson. (1991) Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion. European Journal of Cancer and Clinical Oncology 27:10, pages 1288-1295.
Crossref
Crossref
Bo Fridén, Mikael Rutberg, Johanna Deinum & Margareta Wallin. (1991) The effect of estramustine derivatives on microtubule assembly in vitro depends on the charge of the substituent. Biochemical Pharmacology 42:5, pages 997-1006.
Crossref
Crossref
J.‐E. JOHANSSON, S.‐O. ANDERSSON & L. HOLMBERG. (2008) High‐dose Medroxyprogesterone Acetate versus Estramustine in Therapy‐resistant Prostatic Cancer: A Randomised Study. British Journal of Urology 68:1, pages 67-73.
Crossref
Crossref
Eva von Schoultz, Tommy Bergenheim, Kjell Grankvist & Roger Henriksson. (1991) Estramustine binding protein in human brain-tumor tissue. Journal of Neurosurgery 74:6, pages 962-964.
Crossref
Crossref
H. Becker, K.-H. Bichler, ST. H. Flüchter, U. W. Tunn, G. Ludwig, S. D. Fossa, H. Rübben, U. E. Studer, A. Putz, K. Bandhauer & E. Senn. 1991. Aktuelle Therapie des Prostatakarzinoms. Aktuelle Therapie des Prostatakarzinoms
251
358
.
C.L. Eaton & K. Griffiths. (1990) 5 The role of endocrine therapy in prostatic cancer. Baillière's Clinical Endocrinology and Metabolism 4:1, pages 85-96.
Crossref
Crossref
E. Everitt, H. Ekstrand, B. Boberg & B. Hartley-Asp. (1990) Estramustine phosphate reversibly inhibits an early stage during adenovirus replication. Archives of Virology 111:1-2, pages 15-28.
Crossref
Crossref
John S. Punzi, Debashis Ghosh, Charles M. Weeks, Patrick Van Roey & William L. Duax. (1988) Crystallization of prostatic binding protein. Journal of Steroid Biochemistry 31:4, pages 365-370.
Crossref
Crossref
M.E. Stearns. (1988) Importance of the thiol disulfide status of microtubule proteins for antimitotic drug action. Pharmacology & Therapeutics 37:1, pages 25-36.
Crossref
Crossref
Marc B. Garnick. (1987) Editorial Comment on Hormonal Management of Stage D Carcinoma of the Prostate. Urologic Clinics of North America 14:4, pages 693-694.
Crossref
Crossref
Bo Fridén, Margareta Wallin, Johanna Deinum, Veena Prasad & Richard Luduena. (1987) Effect of estramustine phosphate on the assembly of trypsin-treated microtubules and microtubules reconstituted from purified tubulin with either tau, MAP2, or the tubulin-binding fragment of MAP2. Archives of Biochemistry and Biophysics 257:1, pages 123-130.
Crossref
Crossref
Yair Liel, Aia Biderman, Chaim Biran, Miriam Katz & Martin Sacks. (2006) Carcinoma of the prostate clinically and radiologically simulating malignant lymphoma. Journal of Surgical Oncology 35:2, pages 113-116.
Crossref
Crossref
Mark E. Stearns & Min Wang. (1987) Polarized Pigment Granule Transport Occurs In The Absence Of Microtubules In Squirrelfish Erythrophores: Studies Of The Effects Of Estramustine. Journal of Cell Science 87:4, pages 565-580.
Crossref
Crossref
Pramod C. Sogani & William R. Fair. (1987) Treatment of Advanced Prostatic Cancer. Urologic Clinics of North America 14:2, pages 353-371.
Crossref
Crossref
P.B. Farmer. (1987) Metabolism and reactions of alkylating agents. Pharmacology & Therapeutics 35:3, pages 301-358.
Crossref
Crossref
A. Piccolo, D. Biviano, M. Marullo, E. Saccà & F. Siracusano. (2018) La Nostra Esperienza Con Estracyt Nella Terapia Del Carcinoma Prostatico. Urologia Journal 53:6, pages 898-905.
Crossref
Crossref
Dennis L. Citrin, Carl-bertil Wallemark, Robert Nadler, Carol Geiger, Kathy Tuttle, Edward H. Kaplan & Walter Hauck. (1986) Estramustine affects bone mineral metabolism in metastatic prostate cancer. Cancer 58:10, pages 2208-2213.
Crossref
Crossref
MARGARETA WALLIN, JOHANNA DEINUM & BERYL HARTLEY-ASP. (1986) Estramustine Phosphate Inhibits Microtubule Assembly by Binding to the Microtubule-Associated Proteins. Annals of the New York Academy of Sciences 466:1 Dynamic Aspec, pages 423-425.
Crossref
Crossref
L. DAEHLIN, J.-E. DAMBER, B. SCHOULTZ & B. BERGMAN. (1986) The Oestrogenic Effects of Ethinyl Oestradiol/Polyoestradiol Phosphate and Estramustine Phosphate in Patients with Prostatic Carcinoma A Comparative Study of Oestrogen Sensitive Liver Proteins, Gonadotrophins and Prolactin. British Journal of Urology 58:2-4, pages 412-416.
Crossref
Crossref
Vladimir Petrow & George M. Padilla. (2006) Design of cytotoxic steroids for prostate cancer. The Prostate 9:2, pages 169-182.
Crossref
Crossref
Alvaro Morales & J. Curtis Nickel. (1985) Clinical relevance of plasma testosterone and prolactin changes in advanced cancer of prostate treated with diethylstilbestrol or estramustine phosphate. Urology 26:5, pages 477-481.
Crossref
Crossref
Michael E. Baker. (1985) Evidence that progesterone binding uteroglobin is similar to myosin alkali light chain. FEBS Letters 189:2, pages 188-194.
Crossref
Crossref
W. Vahlensieck, G. Wegner, H. D. Lehmann, G. Franzen, L. Steffens & S. W�hlby. (1985) Comparison between continuous and intermittent administration of Estracyt in the treatment of carcinoma of the prostate. Urological Research 13:5, pages 209-212.
Crossref
Crossref
Margareta Wallin, Johanna Deinum & Bo Fridén. (1985) Interaction of estramustine phosphate with microtubule-associated proteins. FEBS Letters 179:2, pages 289-293.
Crossref
Crossref
George M. Padilla, Vladimir Petrow, Sherry A. Marts & Suresh Mukherji. (2006) Approaches to prostatic cancer chemotherapy using the dunning R3327H prostatic adenocarcinoma. The Prostate 6:2, pages 129-143.
Crossref
Crossref
G. SAETER, SOPHIE D. FOSSÅ, S. OUS, G. P. BLOM & O. KAALHUS. (1984) Carcinoma of the Prostate with Soft Tissue or Non-regional Lymphatic Metastases at the Time of Diagnosis: a Review of 47 Cases. British Journal of Urology 56:4, pages 385-390.
Crossref
Crossref
Yair Walzer, Joye Oswalt & Mark S. Soloway. (1984) Estramustine phosphate-hormone, chemotherapeutic agent, or both?. Urology 24:1, pages 53-58.
Crossref
Crossref
W. Leistenschneider & R. Nagel. (1984) Control of response to estramustine phosphate therapy through cytology and DNA analysis of cell nuclei in prospective study. Urology 23:6, pages 81-88.
Crossref
Crossref
Nelson H. Slack & Gerald P. Murphy. (1984) Clinical toxicity and long-term results of Emcyt therapy for prostate cancer. Urology 23:6, pages 73-77.
Crossref
Crossref
Ralph C. BensonJr.Jr.. (1984) Estramustine phosphate as primary therapy for metastatic prostate cancer. Urology 23:6, pages 69-72.
Crossref
Crossref
Gerald P. Murphy, Nelson H. Slack & Arnold Mittelman. (1984) Use of estramustine phosphate in prostate cancer by the National Prostatic Cancer Project and by Roswell Park Memorial Institute. Urology 23:6, pages 54-63.
Crossref
Crossref
Per Olov Gunnarsson & Gustaf Plym Forshell. (1984) Clinical pharmacokinetics of estramustine phosphate. Urology 23:6, pages 22-27.
Crossref
Crossref
Allen R. Hauser & Ruth Merryman. (2016) Estramustine Phosphate Sodium. Drug Intelligence & Clinical Pharmacy 18:5, pages 368-374.
Crossref
Crossref
Anthony F. Hadfield & Alan C. Sartorelli. 1984.
21
67
.
P. O. Gunnarsson, S. -B. Andersson, S. -�. Johansson, T. Nilsson & G. Plym-Forshell. (1984) Pharmacokinetics of estramustine phosphate (Estracyt�) in prostatic cancer patients. European Journal of Clinical Pharmacology 26:1, pages 113-119.
Crossref
Crossref
Beryl Hartley-Asp. 1984. Cancer Chemotherapy and Selective Drug Development. Cancer Chemotherapy and Selective Drug Development
425
429
.
Per Olov Gunnarsson, Sven-Börje Andersson & Sven-Åke Johansson. (1983) The hydrolysis of estramustine phosphate; in vitro studies. European Journal of Drug Metabolism and Pharmacokinetics 8:4, pages 395-402.
Crossref
Crossref
Michael E. Baker. (1983) Amino acid sequence homology between rat prostatic steroid binding protein and rabbit uteroglobin. Biochemical and Biophysical Research Communications 114:1, pages 325-330.
Crossref
Crossref
F. Bussani, A. Patriti & A. Properzi. (2018) Il Trattamento Del Carcinoma Prostatico Con Estramustina Fosfato: Esperienza Clinica. Urologia Journal 49:6, pages 982-985.
Crossref
Crossref
N.H. Slack, M.F. Brady & Gerald P. Murphy. (1982) Observations of prolonged use of oral emcyt in prostatic cancer patients. Urology 20:5, pages 515-523.
Crossref
Crossref
Malcolm Parker, Maurice Needham & Roger White. (1982) Prostatic steroid binding protein: gene duplication and steroid binding. Nature 298:5869, pages 92-94.
Crossref
Crossref
Beryl Hartley-Asp & Per Olov Gunnarsson. (1982) Growth and Cell Survival Following Treatment with Estramustine, Nor-Nitrogen Mustard, Estradiol and Testosterone of a Human Prostatic Cancer Cell Line (DU 145). Journal of Urology 127:4, pages 818-822.
Crossref
Crossref
W. Hoehn, R. Walther & P. Hermanek. (2006) Human prostatic adenocarcinoma: Comparative experimental treatment of the tumor line pc 82 in nude mice. The Prostate 3:2, pages 193-201.
Crossref
Crossref
Andrea Veronesi, Filiberto Zattoni, Sergio Frustaci, Enzo Galligioni, Umberto Tirelli, Gaetano Trovó, Salvatore Tumolo, Alberto Merlo, Giorgio Artuso, Sergio Cosciani‐Cunico & Eligio Grigoletto. (2006)
Estramustine phosphate (estracyt®) treatment of T
3
–T
4
prostatic carcinoma
. The Prostate 3:2, pages 159-164.
Crossref
Crossref
R. W. GLASHAN & M. R. G. ROBINSON. (2008) Cardiovascular Complications in the Treatment of Prostatic Carcinoma. British Journal of Urology 53:6, pages 624-627.
Crossref
Crossref
Satish Batra & Jonas Müntzing. (1981) Uptake in vivo of 45Ca in male accessory sex organs of the rat: Effect of estramustine phosphate and diethylstilbestrol diphosphate. European Journal of Pharmacology 76:1, pages 87-91.
Crossref
Crossref
Per Olov Gunnarsson, Marianne Ellman, Eva Fabiansson, Kjell Gunnarsson, Gunborg Jensen & Jonas Müntzing. (2009) Antitumour Activity, Toxicity and Disposition of LS 1727, a Nitroso‐Chloroethyl Carbamate of 19‐Nortestosterone, in Rats and Mice. Acta Pharmacologica et Toxicologica 49:4, pages 290-297.
Crossref
Crossref
S. B. Andersson, P. O. Gunnarsson, T. Nilsson & G. Plym Forshell. (1981) Metabolism of estramustine phosphate (Estracyt ®) in patients with prostatic carcinoma. European Journal of Drug Metabolism and Pharmacokinetics 6:2, pages 149-154.
Crossref
Crossref
E. S. E. Hafez. 1980. Prostatic Carcinoma. Prostatic Carcinoma
175
190
.
Bertil Högberg. 1982. Science and Scientists. Science and Scientists
251
255
.
H. FrohmüllerW. Hantelmann, A. Rost, U. Fiedler & W. Brosig. 1981. Verhandlungsbericht der Deutschen Gesellschaft für Urologie. Verhandlungsbericht der Deutschen Gesellschaft für Urologie
168
170
.
Hidetoshi Yamanaka, Kyoichi Imal, Hisako Yuasa & Keizo Shida. (1981) Mechanism of retention of estramustine in the rat prostate and results of a clinical trial of estracyt in Japan. The Prostate 2:S1, pages 95-102.
Crossref
Crossref
Curt Peterson, Per Björk, Björn Forsgren & Bertil Högberg. (2006) Intracellular localization of estramustine in rat ventral prostate in vitro. The Prostate 2:2, pages 143-154.
Crossref
Crossref
Marvin A. Brooks & Ross Dixon. (1980) Determination of estramustine and its 17-keto metabolite in plasma by high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications 182:3, pages 387-394.
Crossref
Crossref
F. Zattoni. (2018) L'Estramustine Fosfato Nel Trattamento Della Neoplasia Prostatica: Risultati Preliminari. Urologia Journal 47:1, pages 148-151.
Crossref
Crossref
S. KHOURY, F. RICHARD, F. FOURCADE, P. FRANTZ & J. P. CAPELLE. (1980) Estramustine Phosphate in the Treatment of Advanced Prostatic Cancer. British Journal of Urology 52:1, pages 29-33.
Crossref
Crossref
I Könyves. 1980. Bladder Tumors and other Topics in Urological Oncology. Bladder Tumors and other Topics in Urological Oncology
493
500
.
H. Reichelt & C. P. Schmidbauer. (1979) Anurie bei fortgeschrittenem Prostatakarzinom. European Surgery 11:6, pages 133-136.
Crossref
Crossref
Jonas Müntzing, Gunborg Jensen & Bertil Högberg. (2009) Pilot Study on the Growth Inhibition by Estramustine Phosphate (Estracyt®) of Rat Mammary Tumours Sensitive and Insensitive to Oestrogen. Acta Pharmacologica et Toxicologica 44:1, pages 1-6.
Crossref
Crossref
A. Danysz, M. Rauf Hamid & K. Wierzba. 1979.
361
376
.
L.‐E. Appelgren, B. Forsgren, J.‐Å. Gustafsson, Å. Pousette & B. Högberg. (2009)
Autoradiographic Studies of
3
H‐estramustine in the Rat Ventral Prostate
. Acta Pharmacologica et Toxicologica 43:5, pages 368-374.
Crossref
Crossref